13 results found.

Breast Neoplasms, Ovarian Neoplasms, Colonic Neoplasms, Prostatic Clinical Trial

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers.

Sexual Dysfunctions, Psychological, Uterine Cervical Neoplasms, O Clinical Trial using GyneGals Support Group

Women's College Hospital - Recruiting 18 years or older.
- A Randomized Controlled Trial of an Online Support Group for Sexual Distress Due to Gynecologic Cancer.
GyneGals Support Group

Ovarian Cancer, Epithelial Tumors, Malignant, Fallopian Tube Canc Clinical Trial using DNIB0600A; pegylated liposomal doxorubicin

Genentech - Recruiting 18 years or older.
- A RANDOMIZED, OPEN-LABEL, MULTICENTER, PHASE II TRIAL EVALUATING THE SAFETY AND ACTIVITY OF DNIB0600A COMPARED TO PEGYLATED LIPOSOMAL DOXORUBICIN ADMINISTERED INTRAVENOUSLY TO PATIENTS WITH PLATINUM-RESISTANT OVARIAN CANCER.
DNIB0600A; pegylated liposomal doxorubicin

Colorectal Neoplasms, Esophageal Neoplasms, or Ovarian Neoplasms Clinical Trial using Indomethacin

UMC Utrecht - Recruiting 18 years to 70 years.
- Phase I Study Evaluating Indomethacin in Combination With Platinum-based Chemotherapy.
Indomethacin

Ovarian Cancer, Cancer of the Ovary, or Ovarian Neoplasms Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Collection of Blood From Patients With Ovarian Cancer.

Ovarian Neoplasms, Peritoneal Neoplasms, or Fallopian Tube Neopla Clinical Trial using Trabectedin; DOXIL; Dexamethasone

Janssen Research & Development, LLC - Recruiting 18 years or older.
- A Randomized, Open-Label Study Comparing the Combination of YONDELIS and DOXIL/CAELYX With DOXIL/CAELYX Monotherapy for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer.
Trabectedin; DOXIL; Dexamethasone

Ovarian Cancer, Peritoneal Neoplasms Clinical Trial

Hoffmann-La Roche - Recruiting 18 years or older.
- A Non-interventional Trial With Avastin as Front-line Treatment for Ovarian Cancer.

Peritoneal Neoplasms Clinical Trial

Hoffmann-La Roche - Recruiting 18 years or older.
- Non-interventional Surveillance Study (NIS) on First-line (FL) Bevacizumab (Avastin) in Combination With Carboplatin/Paclitaxel in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Breast Neoplasms, or Ovarian Neoplasms Clinical Trial

National Institutes of Health Clinical Center (CC) - Recruiting 18 years or older.
- Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer.

Breast Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms, Pancre Clinical Trial using ý1ýPb-TCMC-Trastuzumab; trastuzumab

Areva Med LLC - Recruiting 19 years or older.
- Phase I Trial of Intraperitoneal ý1ýPb-TCMC-Trastuzumab for HER-2 Expressing Malignancy.
ý1ýPb-TCMC-Trastuzumab; trastuzumab

Genital Diseases, Female, Ovarian Diseases, Ovarian Neoplasms, Fa Clinical Trial using Bevacizumab; Paclitaxel; Carboplatin; specialized pathology review (Germany only)

AGO Study Group - Recruiting 18 years or older.
- A Prospective Randomised Phase III Trial to Evaluate Optimal Treatment Duration of First-line Bevacizumab in Combination With Carboplatin and Paclitaxel in Patients With Primary Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer.
Bevacizumab; Paclitaxel; Carboplatin; specialized pathology review (Germany only)

Cervical Cancer, Ovarian Cancer, Endometrial Cancer, Choriocarcin Clinical Trial

Huazhong University of Science and Technology - Recruiting 18 years to 75 years.
- A Large Multicentre Clinical Database and Biobank of Patients With Gynecologic Neoplasms.

Endometrial Neoplasms, Uterine Cervical Neoplasms, Ovarian Neopla Clinical Trial

Walter Reed Army Medical Center - Recruiting 18 years or older.
- Tissue and Data Acquisition Activity for the Study of Gynecological Disease.